Navigation Links
AspenBio Pharma Reports Second Quarter 2007 Results
Date:8/20/2007

712) (2,002) (1,320)

Interest income

(expense):

Interest expense (59) (62) (118) (125)

Interest income 122 24 168 43

Net loss $ (1,084) $ (750) $ (1,952) $ (1,401)

Basic and diluted loss

per share $ (.04) $ (.04) $ (.08) $ (.08)

Basic and diluted weighted

average shares

outstanding 27,070 17,517 24,083 16,806

The notes to the unaudited condensed financial statements available in the company's quarterly statement for the period ended June 30, 2007 as filed with the Securities and Exchange Commission, are an integral part of these statements.

AspenBio Pharma, Inc.

(Unaudited)

Condensed Balance Sheet

(In thousands) June 30, 2007

ASSETS

Cash and cash equivalents $11,162

Other current assets 653

Property and equipment, net 3,395

Other assets, primarily intangibles 1,367

Total assets $16,577

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities $904

Long-term obligations, net 3,039

Total liabilities 3,943

Stockholders' equity 12,634

Total liabilities and stockholders' equity $16,577

The notes to the unaudited condensed financial statements available in the company's quarterly statem
'/>"/>

SOURCE AspenBio Pharma, Inc.

Copyright©2007 PR Newswire.

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Analyzing Trace-Level Impurities of a Pharmaceutical Intermediate Using an LCQ Deca Ion Trap Mass Spectrometer and the Mass Frontier Software Package
2. Rapid SNP Genotyping of the Pharmacogenomically Important Allele CYP2D6*4 Using Real-Time qPCR on the DNA Engine Opticon 2 System
3. Development of a sensitive enzyme fragment complementation assay for cyclic adenosine 3, 5 monophosphate and its validation for pharmacological screening at G protein-coupled receptors
4. Practical Applications of HyperDSC in a Pharmaceutical Laboratory
5. World Class Life Science and Pharmaceutical Companies Leverage DoveBid s Global Reach for Asset Management and Disposition
6. Germantown drug company hires pharma veteran James Davidson as COO
7. Deltanoid Pharmaceuticals begins phase II osteoporosis study
8. New angel capital centered on GenTel agreement with big pharma
9. The deconstruction of Big Pharma
10. Big pharma seeks Wisconsin biotech partnerships
11. Doing the pharmaceutical tango
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/10/2009)... the economy and markets exhibiting continued signs of growth, ... equity research provider, will seek to educate investors on ... cap market at the firm,s First 2010 Micro ... Grand Hyatt Hotel in New York, NY. ... much of Wall Street, but the well-informed investor has ...
(Date:12/10/2009)... - YM BioSciences Inc. (NYSE Amex: YMI ... company that identifies and advances a diverse portfolio ... development, today provided an update on the proposed ... Cytopia Ltd. into YM, details of which were ... directors of Cytopia has unanimously recommended that its ...
(Date:12/10/2009)... Dec. 10 /PRNewswire-Asia-FirstCall/ -- China Biologic,Products, Inc. (Nasdaq: ... one of the,leading plasma-based biopharmaceutical companies in China, ... ring the opening bell at the,NASDAQ MarketSite in ... Tuesday, December 15,2009. , ... NASDAQ Global Market on,December 2, 2009, under the ...
(Date:12/10/2009)... 10 /PRNewswire-Asia/ -- Lotus Pharmaceuticals, Inc.,(OTC Bulletin ... growing developer and,producer of prescription drugs and ... People,s Republic of China ("PRC"), today reported ... controlled operating entity of Lotus,appointed Mr. Jinzhong ... Company,s,Over-the-Counter Drug division ("OTC Division"). , ...
Breaking Biology Technology:Technology, Biotech, Energy and Transportation Among the Industries to be Featured at Sidoti & Company's First Annual 2010 Micro Cap Conference 2YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 2YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 3YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 4China Biologic Products to Ring NASDAQ Opening Bell 2China Biologic Products to Ring NASDAQ Opening Bell 3Lotus Pharmaceuticals, Inc. Appoints OTC Division Head 2Lotus Pharmaceuticals, Inc. Appoints OTC Division Head 3
... Previously Announced Agreement with U.S. Attorney,s, Office for Eastern ... Settles State ... 29 Cephalon, Inc. (Nasdaq:,CEPH) announced today it has ... Attorney,s Office for the Eastern District of,Pennsylvania, the U.S. ...
... -- Receives Recognition in Two Leading Industry Publications ... InNexus,Biotechnology Inc., (OTC Bulletin Board: IXSBF; TSX VENTURE: ... the next,generation of monoclonal antibodies based on its ... and Chairman, to present,during BioContactQuebec 2008. The company ...
... Participation in Upcoming Investor Conferences in ... ... Orexigen Therapeutics,Inc. (Nasdaq: OREX ), a biopharmaceutical company focused on ... active calendar of events for October 2008, which includes,six data presentations ...
Other Biology Technology:Cephalon Concludes All Outstanding Federal and State Government Investigations into the Company's Sales and Promotional Practices 2Cephalon Concludes All Outstanding Federal and State Government Investigations into the Company's Sales and Promotional Practices 3Cephalon Concludes All Outstanding Federal and State Government Investigations into the Company's Sales and Promotional Practices 4InNexus Biotechnology CEO to Present at BioContactQuebec 2008 2Orexigen Therapeutics Announces Multiple Data Presentations at The Obesity Society Annual Scientific Meeting 2
(Date:12/14/2009)... by sneezing, touching, or for Tasmanian devils ... may have driven the dinosaurs to extinction through the ... member of f1000 Biology, highlights the ,paleobiological detective work, ... This led them to deduce that a protozoan parasite ... in many tyrannosaurid fossils. , The parasite,s modern-day equivalent, ...
(Date:12/14/2009)... spending the holidays with big Uncle Frank or bossy ... off with another family, spare a thought for the ... McMaster University and the University of New South Wales ... in groups, members make strategic decisions about their living ... issue of Biology Letters . , The helper ...
(Date:12/14/2009)... United Nations Framework Convention on Climate Change taking ... the ,Bend the Trend, event on Sunday evening ... premiere the screening of the new ,Environmental Atlas ... a joint project of the European Environment Agency ... is a series of short films showing the ...
Breaking Biology News(10 mins):'Environmental Atlas of Europe' unveiled at COP15 2Brain Protein Tied to Retardation 59897 1iLife Americas LLC Enters U S Wellness and Therapeutic Markets 14561 1iLife Americas LLC Enters U S Wellness and Therapeutic Markets 14561 2DUSA Pharmaceuticals Named to Deloittes 2009 Technology Fast 500 List of Fastest Growing Companies in North America 59892 1DUSA Pharmaceuticals Named to Deloittes 2009 Technology Fast 500 List of Fastest Growing Companies in North America 59892 2DUSA Pharmaceuticals Named to Deloittes 2009 Technology Fast 500 List of Fastest Growing Companies in North America 59892 3
... Breast cancer patients face many horrors, including those ... given during chemotherapy can have wicked side effects, ... side effects occur because medications released into the ... cells. , The trick becomes how to deliver ...
... (March 10, 2009)Interventional radiologists are fitting together the puzzle ... new or more blood vessels to treat peripheral arterial ... clogged arteries. That puzzle may be closer to being ... simple imaging to view and locate transplanted stem cells ...
... Oversees Software Development, Operations, Information Technology and Security ... the leader in on-demand identity intelligence, announced today ... its chief information officer. Pathman is a senior ... record of using leading edge technology at high ...
Other Biology News:Twin nanoparticle shown effective at targeting, killing breast cancer cells 2'Seeing' stem cells helps in fight against peripheral arterial disease 2'Seeing' stem cells helps in fight against peripheral arterial disease 3'Seeing' stem cells helps in fight against peripheral arterial disease 4ID Analytics Appoints Chief Information Officer 2